IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Nymox Pharmaceutical Corp. & Advises Investors with Lo...
August 10 2016 - 10:25PM
Business Wire
Lundin Law PC (http://lundinlawpc.com/) announces that it is
investigating claims against Nymox Pharmaceutical Corporation
(“Nymox” or the “Company”) (Nasdaq: NYMX) concerning possible
violations of federal securities laws.
To get more information about this investigation, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
email at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class
is certified, you are not considered represented by an attorney.
You may also choose to do nothing and be an absent class
member.
The investigation concerns whether Nymox and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934. On August 10, 2016, an article
was published in Seeking Alpha reporting that the Company’s
management misled shareholders about its prospects while
aggressively dumping stock without timely SEC disclose. When this
news was announced, shares of Nymox fell in value.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160810006259/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Mar 2023 to Mar 2024